Medicare's disproportionate share adjustment and the cost of low-income patients
ResearchPublished 1997
ResearchPublished 1997
This study investigates whether or not hospitals have higher costs for inpatient care provided to low-income Medicare patients, after controlling for other cost differences already accounted for by Medicare payments. Differences were estimated in Prospective Payment System-adjusted costs and outlier-adjusted length of stay for low-income patients relative to matching non-low-income cases from the same hospital in 85 high-volume diagnosis-related groups. Low-income Medicare patients do not have costlier hospital stays, although their stays are 2.5% longer. The authors conclude that disproportionate share payments are not justified on grounds of higher treatment costs.
Originally published in: Journal of Health Economics, v. 16, 1997, pp. 177-190.
This publication is part of the RAND reprint series. The reprint series, a product of RAND from 1992 to 2011, included previously published journal articles, book chapters, and reports that were reproduced by RAND with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see external publications.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.